cidofovir anhydrous has been researched along with Body Weight in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buller, RM; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B | 1 |
| Ennis, J; Russell, A; Smee, DF; Turner, JD; Wong, MH | 1 |
| Bailey, KW; Beadle, JR; Hostetler, KY; Sidwell, RW; Smee, DF; Wong, MH | 1 |
| Baldwin, TJ; Gowen, BB; Hoopes, JD; Sidwell, RW; Skirpstunas, RT; Smee, DF; Wandersee, MK; Wong, MH | 1 |
| Andrei, G; De Clercq, E; Liekens, S; Neyts, J; Vandeputte, M | 1 |
| Bolger, G; Bousquet, C; Cordingley, M; Garneau, M; Kibler, P; Lapeyre, N; Rhéaume, M | 1 |
| Bailey, KW; Sidwell, RW; Smee, DF | 2 |
| Galofré, JC; Idoate, M; Redondo, P; Solano, T | 1 |
| Bailey, KW; Sidwell, RW; Smee, DF; Wong, MH | 1 |
| Bray, M; Kefauver, D; Martinez, M; Roy, C; West, M | 1 |
11 other study(ies) available for cidofovir anhydrous and Body Weight
| Article | Year |
|---|---|
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Liver; Mesocricetus; Organophosphonates; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load | 2014 |
Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201).
Topics: Adenoviridae; Administration, Intranasal; Animals; Body Weight; Cidofovir; Cytosine; Female; Genetic Vectors; Interferon-alpha; Mice; Mice, Inbred BALB C; Organophosphonates; Protective Agents; Respiratory Tract Infections; Survival Analysis; Time Factors; Vaccinia; Vaccinia virus | 2011 |
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Heart; Liver; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Oxygen; Purines; Respiratory Tract Infections; Ribavirin; Salivary Glands; Spleen; Treatment Outcome; Vaccinia; Vaccinia virus; Viral Plaque Assay; Viremia | 2004 |
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Body Weight; Chemokines; Cidofovir; Cowpox; Cowpox virus; Cytokines; Cytosine; Female; Giant Cells; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates | 2008 |
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Brain Neoplasms; Cidofovir; Cytosine; Hemangioma; Incidence; Organophosphonates; Organophosphorus Compounds; Polyomavirus; Rats; Rats, Wistar; Skin Neoplasms; Survival Analysis | 1998 |
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Body Weight; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Ganciclovir; Hepatitis, Viral, Animal; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication | 1999 |
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Respiratory Tract Infections; Ribavirin; Vero Cells; Viral Plaque Assay | 2000 |
Cidofovir inhibits growth of B16 melanoma cells in vivo.
Topics: Animals; Antineoplastic Agents; Body Weight; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Skin Neoplasms | 2000 |
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Blood Gas Monitoring, Transcutaneous; Body Weight; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Injections, Intraperitoneal; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates; Organophosphorus Compounds; Respiratory System; Respiratory Tract Infections; Time Factors; Vaccinia; Vaccinia virus; Vero Cells; Viral Plaque Assay; Virus Replication | 2001 |
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
Topics: Administration, Inhalation; Aerosols; Animals; Antiviral Agents; Body Weight; Bronchopneumonia; Cidofovir; Cowpox; Cowpox virus; Cytosine; Female; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates; Organophosphorus Compounds; Statistics, Nonparametric | 2002 |
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Topics: Animals; Antiviral Agents; Area Under Curve; Body Weight; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Nasal Mucosa; Organophosphonates; Organophosphorus Compounds; Prodrugs; Purines; Statistics, Nonparametric; Vero Cells | 2002 |